These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7687635

  • 1. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.
    Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C.
    J Immunol; 1993 Aug 01; 151(3):1562-70. PubMed ID: 7687635
    [Abstract] [Full Text] [Related]

  • 2. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ.
    Lab Invest; 1996 Jun 01; 74(6):1039-49. PubMed ID: 8667608
    [Abstract] [Full Text] [Related]

  • 3. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI, Altomonte M, Fonsatti E, Colizzi F, Coral S, Nicotra MR, Cattarossi I, Cattelan A, Natali PG, Maio M.
    Lab Invest; 1996 Jan 01; 74(1):33-42. PubMed ID: 8569195
    [Abstract] [Full Text] [Related]

  • 4. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S, van den Berg CW.
    Xenotransplantation; 2005 May 01; 12(3):217-26. PubMed ID: 15807772
    [Abstract] [Full Text] [Related]

  • 5. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M, Sugita Y, Seya T.
    Eur J Immunol; 1991 Aug 01; 21(8):1787-92. PubMed ID: 1714391
    [Abstract] [Full Text] [Related]

  • 6. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S, Frolkis I, Rashkovsky L, Ophir D, Fishelson Z.
    Am J Respir Cell Mol Biol; 1996 Dec 01; 15(6):731-7. PubMed ID: 8969267
    [Abstract] [Full Text] [Related]

  • 7. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA, van Wieringen PA, van Es LA, Daha MR.
    Eur J Immunol; 1992 Dec 01; 22(12):3135-40. PubMed ID: 1280224
    [Abstract] [Full Text] [Related]

  • 8. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A, Junnikkala S, Hakulinen J, Timonen T, Meri S.
    Am J Pathol; 1996 Apr 01; 148(4):1139-52. PubMed ID: 8644856
    [Abstract] [Full Text] [Related]

  • 9. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR.
    Virology; 1994 Nov 15; 205(1):82-92. PubMed ID: 7526538
    [Abstract] [Full Text] [Related]

  • 10. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR, Blom DJ, de Waard-Siebinga I, van Beelen E, Claas FH, Jager MJ, Gorter A.
    Invest Ophthalmol Vis Sci; 1996 Aug 15; 37(9):1884-91. PubMed ID: 8759358
    [Abstract] [Full Text] [Related]

  • 11. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
    Clayton A, Harris CL, Court J, Mason MD, Morgan BP.
    Eur J Immunol; 2003 Feb 15; 33(2):522-31. PubMed ID: 12645951
    [Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
    Saifuddin M, Hedayati T, Atkinson JP, Holguin MH, Parker CJ, Spear GT.
    J Gen Virol; 1997 Aug 15; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
    [Abstract] [Full Text] [Related]

  • 13. Primary human hepatocytes are protected against complement by multiple regulators.
    Halme J, Sachse M, Vogel H, Giese T, Klar E, Kirschfink M.
    Mol Immunol; 2009 Jul 15; 46(11-12):2284-9. PubMed ID: 19446335
    [Abstract] [Full Text] [Related]

  • 14. Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells.
    Accardo-Palumbo A, Triolo G, Colonna-Romano G, Potestio M, Carbone M, Ferrante A, Giardina E, Caimi G, Triolo G.
    Diabetologia; 2000 Aug 15; 43(8):1039-47. PubMed ID: 10990082
    [Abstract] [Full Text] [Related]

  • 15. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG, Spendlove I.
    Curr Opin Investig Drugs; 2001 Jul 15; 2(7):959-66. PubMed ID: 11757799
    [Abstract] [Full Text] [Related]

  • 16. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
    Ziller F, Macor P, Bulla R, Sblattero D, Marzari R, Tedesco F.
    Eur J Immunol; 2005 Jul 15; 35(7):2175-83. PubMed ID: 15971270
    [Abstract] [Full Text] [Related]

  • 17. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S, Shirakura R, Nakata S, Izutani H, Matsuda H, Iwata K, Nagasawa S, Terado A, Hatanaka M, Matsumoto M.
    Transplant Proc; 1995 Feb 15; 27(1):328-9. PubMed ID: 7533401
    [No Abstract] [Full Text] [Related]

  • 18. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ, White D, Tedja I, Liszewski K, Wright L, Van den Bogarde J, Atkinson JP.
    Trans Assoc Am Physicians; 1991 Feb 15; 104():164-72. PubMed ID: 1726964
    [No Abstract] [Full Text] [Related]

  • 19. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.
    Sullivan BL, Knopoff EJ, Saifuddin M, Takefman DM, Saarloos MN, Sha BE, Spear GT.
    J Immunol; 1996 Aug 15; 157(4):1791-8. PubMed ID: 8759769
    [Abstract] [Full Text] [Related]

  • 20. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis.
    Cole DS, Hughes TR, Gasque P, Morgan BP.
    Mol Immunol; 2006 May 15; 43(12):1953-64. PubMed ID: 16406094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.